A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.
体外研究
A-205804 exhibits Cellular Toxicities for HUVEC with an IC50 of 152 μM.
A-205804 is an effective inhibitor of cell-cell adhesion in an in vitro flow experiment, demonstrating relevance in a model physiological system.
体内研究
A-205804 (5 mg/kg; p.o.) shows a half-life of 1 hour for rat.
A-205804 (10 mg/kg; p.o.; 3 times per week; for 2 weeks) attenuates the E-selectin expression on the endothelial vascular niche cells in mice.
Animal Model:
C57BL/6 mice
Dosage:
10 mg/kg
Administration:
Oral administration, 3 times per week, for 2 weeks
Result:
Efficiently decreased the expression of E-selectin on the endothelial vascular niche cells
Animal Model:
Rat
Dosage:
5 mg/kg (Pharmacokinetic Analysis)
Administration:
Oral administration
Result:
t1/2 = 1 hour
分子式
C15H12N2Os2
分子量
300.40
CAS号
251992-66-2
运输条件
Room temperature in continental US; may vary elsewhere.